Advertisement

Topics

Janssen's diabetes drug wins FDA nod

05:15 EDT 22 Sep 2016 | SmartBrief

Janssen Pharmaceuticals' Invokamet XR, an extended-release combination of canagliflozin and metformin, has been approved by t -More

Original Article: Janssen's diabetes drug wins FDA nod

NEXT ARTICLE

More From BioPortfolio on "Janssen's diabetes drug wins FDA nod"

Quick Search
Advertisement